MTSS1 and nasopharyngeal carcinoma: MTSS1 expression is relatively low in breast cancer [3], glioblastoma [4], diffuse large B-cell lymphoma (DLBCL) [5], and nasopharyngeal carcinoma [6] compared with control tissue from healthy subjects.